NEW YORK (Reuters Health) – The seroprevalence of Coxiella burnetii – the causative organism of the zoonotic disease Q-fever – is high among US veterinarians, particularly those who…
NEW YORK (Reuters Health) – In the real-world setting of contemporary clinical cardiology practices, adverse events following percutaneous cardiovascular procedures are substantially reduced by using radial artery access…
NEW YORK (Reuters Health) – Rituximab appears to be of benefit to some patients with severe proliferative or membranous lupus nephritis, according to a small French study published…
NEW YORK (Reuters Health) – Women with depressive symptoms are at increased risk for developing coronary heart disease (CHD), especially fatal CHD, according to findings from the Nurses’…
NEW YORK (Reuters Health) – Patients who are admitted on a weekend for bleeding peptic ulcers have worse survival than their peers admitted on a weekday, according to…
NEW YORK (Reuters Health) – By reducing dyspnea and increasing exercise tolerance, breathing a mixture of 60% helium and 40% oxygen augments the benefits of physical rehabilitation in…
NEW YORK (Reuters Health) – Although it is safe, low-dose vitamin K used to treat warfarin recipients with high INRs (international normalized ratios) does not reduce episodes of…
NEW YORK (Reuters Health) – For first-line tocolytic therapy before 32 weeks’ gestation, prostaglandin inhibitors appear to be the most effective and tolerable agents for delaying delivery for…
NEW YORK (Reuters Health) – People with a family history of intracranial aneurysm are known to be at increased risk themselves, but now new research questions prior findings…
NEW YORK (Reuters Health) – After finding that the 5-HT3 receptor in the brain affects susceptibility to opioid dependence, scientists in California have demonstrated the efficacy of ondansetron,…